Endovascular Treatment of Peripheral Vascular Disease

Current Problems in Cardiology

Volumn 34, Issue 9, 2009, Pages 359-476

  Allaqaband, Suhail ^a   Kirvaitis, Romas ^a   Jan, Fuad ^a   Bajwa, Tanvir ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CILOSTAZOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOLYTIC AGENT; FIBROBLAST GROWTH FACTOR 2; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; NAFTIDROFURYL; PENTOXIFYLLINE; RETEPLASE; STREPTOKINASE; TENECTEPLASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; VASCULOTROPIN 121; WARFARIN;

ABDOMINAL AORTA ANEURYSM; AGE; ANKLE BRACHIAL INDEX; AORTOFEMORAL BYPASS; ARTERY DISEASE; ARTICLE; AXILLARY VEIN; BARE METAL STENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CEREBROVASCULAR DISEASE; CLAUDICATION; CLINICAL FEATURE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; COST CONTROL; DEEP VEIN THROMBOSIS; DIAGNOSTIC VALUE; DIARRHEA; DISEASE CLASSIFICATION; DRUG EFFICACY; DRUG ELUTING STENT; DRUG INDUCED HEADACHE; DRUG MEGADOSE; EMBOLECTOMY; ENDOVASCULAR SURGERY; FEMORAL ARTERY; FEMOROPOPLITEAL BYPASS; GLYCEMIC CONTROL; HEART PALPITATION; HOSPITAL COST; HUMAN; ILIAC ARTERY OBSTRUCTION; IN-STENT RESTENOSIS; INTERMITTENT CLAUDICATION; INTESTINE ISCHEMIA; KIDNEY ARTERY STENOSIS; LERICHE SYNDROME; LIMB ISCHEMIA; LIMB SALVAGE; LOW DRUG DOSE; LUNG EMBOLISM; MECHANICAL THROMBECTOMY; MESENTERIC ARTERY OCCLUSION; MORBIDITY; MORTALITY; PATHOPHYSIOLOGY; PERCUTANEOUS THROMBECTOMY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; PHYSICAL ACTIVITY; PREVALENCE; RISK FACTOR; SMOKING CESSATION; STROKE; SUBCLAVIAN ARTERY; SUPERIOR CAVA VEIN SYNDROME; THERAPY EFFECT; THORACIC AORTA ANEURYSM; VENA CAVA FILTER; WEIGHT CONTROL;

AGED; ANEURYSM; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; CLINICAL PROTOCOLS; ENDARTERECTOMY, CAROTID; FEMALE; HUMANS; MALE; PERIPHERAL VASCULAR DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STENTS; TREATMENT OUTCOME; VENA CAVA FILTERS;

EID: 68049091109     PISSN: 01462806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cpcardiol.2009.05.001     Document Type: Article

References (412)

1. Diehm C., Schuster A., Allenberg J.R., et al. High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: Cross-sectional study. Atherosclerosis 172 (2004) 95-105
2. Zheng Z.J., Sharrett A.R., Chambless L.E., et al. Associations of ankle-brachial index with clinical coronary heart disease, stroke and preclinical carotid and popliteal atherosclerosis: The atherosclerosis risk in communities (ARIC) study. Atherosclerosis 131 (1997) 115-125
3. Fowkes F.G.R., Housley E., Cawood E.H.H., et al., Edinburgh Artery Study. Prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 20 (1991) 384-392
4. Newman A.B., Sutton-Tyrrell K., Rutan G.H., et al. Lower extremity arterial disease in elderly subjects with systolic hypertension. J Clin Epidemiol 44 (1991) 15-20
5. Criqui M.H., Langer R.D., Fronek A., et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326 (1992) 381-386
6. Hirsch A.T., Haskal Z.J., Hertzer N.R., et al. ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): A Collaborative Report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology, Society for Vascular Medicine and Biology and The American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease). J Am Coll Cardiol 47 (2006) 1239-1312
7. Newman A.B., Shemanski L., Manolio T.A., et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the cardiovascular health study. Arterioscler Thromb Vasc Biol 19 (1999) 538-545
8. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (Caprie). Lancet 348 (1996) 1329-1339
9. Baumgartner I., Hirsch A.T., Abola T.B., et al. Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: Data from the Reduction Of Atherothrombosis For Continued Health (REACH) Registry. J Vasc Surg 48 (2008) 808-813
10. Fowkes F.G., Low L.P., Tuta S., et al., AGATHA Investigators. Ankle brachial index and the extent of atherothrombosis in 8891 patients with or at risk of vascular disease: Results of the international AGATHA study. Eur Heart J 27 (2006) 1861-1867
11. Criqui M.H., Denenberg J.O., Langer R.D., et al. The epidemiology of peripheral arterial disease: Importance of identifying the population at risk. Vasc Med 2 (1997) 221-226
12. Price J.F., Mowbray P.I., Lee A.J., et al. Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease: Edinburgh artery study. Eur Heart J 20 (1999) 344-353
13. Barani J., Nilsson J.A., Matiasson I., et al. Inflammatory mediators are associated with 1-year mortality in critical limb ischemia. J Vasc Surg 42 (2005) 75-80
14. McDermott M.M., Greenland P., Guralnik J.M., et al. Depressive symptoms and lower extremity functioning in men and women with peripheral arterial disease. J Gen Intern Med 18 (2003) 461-467
15. McDermott M.M., Liu K., Greenland P., et al. Functional decline in peripheral arterial disease: Associations with the ankle brachial index and leg symptoms. J Am Med Assoc 292 (2004) 453-461
16. Hirsch A.T., Criqui M.H., Treat-Jacobson D., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. J Am Med Assoc 286 (2001) 1317-1324
17. Norgren L., Hiatt W.R., Dormandy J.A., et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45 suppl (2007) S5-S67
18. Dormandy J.A., and Murray G.D. The fate of the claudicant: A prospective study of 1969 claudicants. Eur J Vasc Surg 5 (1991) 131-133
19. Jelnes R., Gaardsting O., Hougaard Jensen K., et al. Fate in intermittent claudication: Outcome and risk factors. Br Med J 293 (1986) 1137-1140
20. Belch J.J., Topol E.J., Agnelli G., et al. Prevention of Atherothrombotic Disease Network. Critical issues in peripheral arterial disease detection and management: A call to action. Arch Intern Med 163 (2003) 884-892
21. Dormandy J.A., Heeck L., and Vig S. The fate of patients with critical leg ischemia. Semin Vasc Surg 12 (1999) 142-147
22. DeGowin R., and DeGowin E. The blood vessels/circulation of limbs. In: DeGowin E.L., and DeGowin R.L. (Eds). DeGowin And DeGowin'S Bedside Diagnostic Examination. 5th edition (1987), Macmillan, New York, NY 415-466
23. Woods B.O. Clinical evaluation of the peripheral vasculature. Cardiol Clin 9 (1991) 413-427
24. Ouriel K., McDonnell A.E., Metz C.E., et al. Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery 91 (1982) 686-693
25. Baxter G.M., and Polak J.F. Lower limb colour flow imaging: A comparison with ankle: Brachial measurements and angiography. Clin Radiol 47 (1993) 91-95
26. Doobay A.V., and Anand S.S. Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: A systematic review. Arterioscler Thromb Vasc Biol 25 (2005) 1463-1469
27. Newman A.B., Siscovick D.S., Manolio T.A., et al., Cardiovascular Health Study (CHS) Collaborative Research Group. Ankle-arm index as a marker of atherosclerosis in the cardiovascular health study. Circulation 88 (1993) 837-845
28. Sumner D.S., and Strandness Jr. D.E. The relationship between calf blood flow and ankle blood pressure in patients with intermittent claudication. Surgery 65 (1969) 763-771
29. Olin JW. Clinical evaluation and office-based detection of peripheral arterial disease. Society for Vascular Medicine and Biology and Society for Vascular Nursing. Peripheral Arterial Disease: Marker of Cardiovascular Risk. Manchester, Mass: SVMB/SVM; 1999. http://www.svmb.org/medpro/cme/pl/cme_partl.html (accessed November 2, 2000).
30. Sacks D., Bakal C.W., Beatty P.T., et al. Position statement on the use of the ankle-brachial index in the evaluation of patients with peripheral vascular disease: A consensus statement developed by the standards division of the Society of Cardiovascular and Interventional Radiology. J Vasc Interv Radiol 13 (2002) 353
31. Resnick H.E., Lindsay R.S., McDermott M.M., et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: The strong heart study. Circulation 109 (2004) 733-739
32. Collins R., Armitage J., Parish S., et al., Heart Protection Study Collaborative Group. MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals. A randomised placebo-controlled trial. Lancet 360 (2002) 7-22
33. Feringa H.H., Karagiannis S.E., van Waning V.H., et al. The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial disease. J Vasc Surg 45 (2007) 936-943
34. Poldermans D., Bax J.J., Kertai M.D., et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 107 (2003) 1848-1851
35. Schillinger M., Exner M., Mlekusch W., et al. Statin therapy improves cardiovascular outcome of patients with peripheral artery disease. Eur Heart J 25 (2004) 742-748
36. Gardner A.W., and Poehlman E.T. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. J Am Med Assoc 274 (1995) 975-980
37. Hood S.C., Moher D., and Barber G.G. Management of intermittent claudication with pentoxifylline: Meta-analysis of randomized controlled trials. CMAJ 155 (1996) 1053
38. Regensteiner J.G., Ware Jr. J.E., McCarthy W.J., et al. Effect of cilostazol on treadmill walking, community based walking ability and health related quality of life in patients with intermittent claudication due to peripheral arterial disease: Metaanalysis of six randomized controlled trials. J Am Geriatr Soc 50 (2002) 1939-1946
39. North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 325 (1991) 445-453
40. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study (ACAS). Endarterectomy for asymptomatic carotid artery stenosis. J Am Med Assoc 273 (1995) 1421-1428
41. Biller J., Feinberg W.M., Castaldo J.E., et al. Guidelines for carotid endarterectomy. AHA scientific statement. Circulation 97 (1998) 501-509
42. Yadav J.S., Roubin G.S., Iyer S., et al. Elective stenting of the extracranial carotid arteries. Circulation 95 (1997) 376-381
43. Wholey M.H., Wholey M., Mathias K., et al. Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv 50 (2000) 160-167
44. Lin P.H., Bush R.L., Peden E.K., et al. Carotid artery stenting with neuroprotection: Assessing the learning curve and treatment outcome. Am J Surg 190 (2005) 850-857
45. Mathias K.D. Angioplasty and stenting for carotid lesions. Adv Surg 32 (2002) 225-243
46. Cremonesi A., Manetti R., Setacci F., et al. Protected carotid stenting: Clinical advantages and complications of embolic protection devices in 442 consecutive patients. Stroke 34 (2003) 1936-1941
47. Ribo M., Molina C.A., Alvarez B., et al. Transcranial Doppler monitoring of transcervical carotid stenting with flow reversal protection: A novel carotid revascularization technique. Stroke 37 (2006) 2846-2849
48. Ohki T. The dark side of embolic protection devices. Endovasc Today 9 (2003) 111-119
49. Reimers B., Corvaja N., Moshiri S., et al. Cerebral protection with filter devices during carotid artery stenting. Circulation 104 (2001) 12-15
50. Yadav J.S., Wholey M.H., Kuntz R.E., et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 351 (2004) 1493-1501
51. Gurm H.S., Yadav J.S., Fayad P., et al. Long-term results of carotid stenting versus endarterectomy in high-risk patients. N Engl J Med 358 (2008) 1572-1579
52. Harjai K.J., and Mehta R.H. Trials and tribulations of carotid artery stenting: The interventionalists' perspective on sapphire, EVA-3S, and SPACE trials. J Interv Cardiol 20 (2007) 389-394
53. Mas J.L., Chatellier G., Beyssen B., et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 355 (2006) 1660-1671
54. Mas J.L., Trinquart L., Leys D., et al. Endarterectomy versus angioplasty in patients with symptomatic severe carotid stenosis (EVA-3S) trial: Results up to 4 years from a randomized, multicenter trial. Lancet Neurol 7 (2008) 885-892
55. Ringleb P.A., Allenberg J., Berger J., et al., SPACE Collaborative Group. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients. A randomised non-inferiority trial. Lancet 368 (2006) 1239-1247
56. Eckstein H.H., Ringleb P., Allenberg J.R., et al. Results of the stent-protected angioplasty versus carotid endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: A multinational, prospective, randomised trial. Lancet Neurol 7 (2008) 893-902
57. Roubin G.S., Iyer S., Halkin A., et al. Realizing the potential of carotid artery stenting: Proposed paradigms for patient selection and procedural technique. Circulation 113 (2006) 2021-2030
58. Peel G., Wholey M.H., Hagino R.T., et al. Percutaneous carotid artery intervention: A word of caution about mixing stent/filter systems. J Endovasc Ther 14 (2007) 110-112
59. Markus H.S., Droste D.W., Kaps M., et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: The clopidogrel and aspirin for reduction of emboli in symptomatic carotid stenosis (caress) trial. Circulation 111 (2005) 2233-2240
60. White C.J., Iyer S.S., Hopkins L.N., et al., BEACH Trial Investigators. Carotid stenting with distal protection in high surgical risk patients: The BEACH trial 30 day results. Catheter Cardiovasc Interv 67 (2006) 503-512
61. Iyer S.S., White C.J., Hopkins L.N., et al. Carotid artery revascularization in high-surgical-risk patients using the carotid WALLSTENT and FilterWire ex/EZ: 1-year outcomes in the BEACH pivotal group. J Am Coll Cardiol 51 (2008) 427-434
62. White R.A., Diethrich E., Fogarty T.J., et al., CaRESS Steering Committee. Carotid revascularization using endarterectomy or stenting systems (CaRESS) Phase I clinical trial: 1-year results. J Vasc Surg 42 (2005) 213-219
63. Sugita J., Cremonesi A., Van Elst F., et al. European carotid PROCAR trial: Prospective multicenter trial to evaluate the safety and performance of the ev3 protégé stent in the treatment of carotid artery stenosis-1- and 6-month follow-up. J Interv Cardiol 19 (2006) 215-221
64. Gray W.A., Yadav J.S., Verta P., et al. The CAPTURE registry: Results of carotid stenting with embolic protection in the post approval setting. J Vasc Surg 42 (2005) 213-219
65. Gray W.A., Yadav J.S., Verta P., et al. The CAPTURE registry: Results of carotid stenting with embolic protection in the post approval setting. Catheter Cardiovasc Interv 69 (2007) 341-348
66. Safian R.D., Bresnahan J.F., Jaff M.R., et al. Protected carotid stenting in high-risk patients with severe carotid artery stenosis. J Am Coll Cardiol 47 (2006) 2384-2389
67. Katzen B.T., Criado F.J., Ramee S.R., et al. Carotid artery stenting with emboli protection surveillance study: Thirty-day results of the CASES-PMS study. Catheter Cardiovasc Interv 70 (2007) 316-323
68. Berguer R., Flynn L.M., Kline R.A., et al. Surgical reconstruction of the extracranial vertebral artery: Management and outcome. J Vasc Surg 31 (2000) 9-18
69. Jenkins J.S., White C.J., Ramee S.R., et al. Vertebral artery stenting. Catheter Cardiovasc Interv 54 (2001) 1-5
70. Malek A.M., Higashida R.T., Phatouros C.C., et al. Treatment of posterior circulation ischemia with extracranial percutaneous balloon angioplasty and stent placement. Stroke 30 (1999) 2073-2085
71. Beebe H.G., Stark R., Johnson M.L., et al. Choices of operation for subclavian vertebral arterial disease. Am J Surg 139 (1980) 616-623
72. Hadjipetrou P., Cox S., Piemonte T., et al. Percutaneous revascularization of atherosclerotic obstruction of aortic arch vessels. J Am Coll Cardiol 33 (1999) 1238-1245
73. Rodriguez-Lopez J.A., Werner A., Martinez R., et al. Stenting for atherosclerotic occlusive disease of the subclavian artery. Ann Vasc Surg 13 (1999) 254-260
74. Al-Mubarak N., Liu M.W., Dean L.S., et al. Immediate and late outcomes of subclavian artery stenting. Catheter Cardiovasc Interv 46 (1999) 169-172
75. Jain S.P., Zhang S.Y., Khosla S., et al. Subclavian and innominate arteries stenting: Acute and long term results. J Am Coll Cardiol 31 (1998) 63A
76. Jean W.J., Al-bitar I., Zwicke D.L., et al. High incidence of renal artery stenosis in patients with coronary artery disease. Catheter Cardiovasc Interv 32 (1994) 8-10
77. Weber-Mzell D., Kotanko P., Schumacher M., et al. Coronary anatomy predicts presence or absence of renal artery stenosis. A prospective study in patients undergoing cardiac catheterization for suspected coronary artery disease. Eur Heart J 23 (2002) 1684-1691
78. Buller C.E., Nogareda J.G., Ramanathan K., et al. The profile of cardiac patients with renal artery stenosis. J Am Coll Cardiol 43 (2004) 1606-1613
79. Caps M.T., Perissinotto C., Zierler R.E., et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 98 (1998) 2866-2872
80. Caps M.T., Zierler R.E., Polissar N.L., et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int 53 (1998) 735-742
81. Hansen K.J., Starr S.M., Sands R.E., et al. Contemporary surgical management of renovascular disease. J Vasc Surg 16 (1991) 319-331
82. Textor S.C. Renovascular hypertension in 2007: Where are we now?. Curr Cardiol Rep 9 (2007) 453-461
83. Welch W.J., Mendonca M., Aslam S., et al. Roles of oxidative stress and AT1 receptors in renal hemodynamics and oxygenation in the postclipped 2K,1C kidney. Hypertension 41 (2003) 692-696
84. Parildar M., Parildar Z., Oran I., et al. Nitric oxide and oxidative stress in atherosclerotic renovascular hypertension: Effects of endovascular treatment. J Vasc Interv Radiol 14 (2003) 887-892
85. Balk E., Raman G., Chung M., et al. Effectiveness of management strategies for renal artery stenosis: A systematic review. Ann Intern Med 145 (2006) 901-912
86. Silva J.A., Chan A.W., White C.J., et al. Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis. Circulation 111 (2005) 328-333
87. Mitchell J.A., Subramanian R., White C.J., et al. Predicting blood pressure improvement in hypertensive patients after renal artery stent placement: Renal fractional flow reserve. Catheter Cardiovasc Interv 69 (2007) 685-689
88. Kidney D., and Deutsch L.S. The indications and results of percutaneous transluminal angioplasty and stenting in renal artery stenosis. Semin Vasc Surg 9 (1996) 188-197
89. Lederman R.J., Mendelsohn F.O., Santos R., et al. Primary renal artery stenting: Characteristics and outcomes after 363 procedures. Am Heart J 142 (2001) 314-323
90. Burket M.W., Cooper C.J., Kennedy D.J., et al. Renal artery angioplasty and stent placement: Predictors of a favorable outcome. Am Heart J 139 (2000) 64-71
91. Rodriguez-Lopez J.A., Werner A., Ray L.I., et al. Renal artery stenosis treated with stent deployment: Indications, technique, and outcome for 108 patients. J Vasc Surg 29 (1999) 617-624
92. Rocha-Singh K.J., Mishkel G., Katholi R.E., et al. Clinical predictors of improved long-term blood pressure control after successful stenting of hypertensive patients with obstructive renal artery atherosclerosis. Catheter Cardiovasc Interv 47 (1999) 167-172
93. Dorros G., Jaff M., Mathiak L., et al. Four-year follow-up of Palmaz-Schatz Stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 98 (1998) 642-647
94. White C.J., Ramee S.R., Collins T.J., et al. Renal artery stent placement: Utility in lesions difficult to treat with balloon angioplasty. J Am Coll Cardiol 30 (1997) 1445-1450
95. Allaqaband S., Shaikh F., Zaidi S., et al. Blood pressure control after renal artery stenting in 100 consecutive hypertensive patients with atherosclerotic renal artery stenosis. Am J Cardiol 92 (2003) 53L
96. Dorros G., Jaff M., Mathiak L., et al. Multicenter PALMAZ stent renal artery stenosis revascularization registry report: Four-year follow-up of 1058 successful patients. Catheter Cardiovasc Interv 55 (2002) 182-188
97. Rocha-Singh K., Jaff M.R., Rosenfield K., and Aspire-2 Trial Investigators. evaluation of the safety and effectiveness of renal artery stenting after unsuccessful balloon angioplasty: The aspire-2 study. J Am Coll Cardiol 46 (2005) 776-783
98. Mistry S., Ives N., Harding J., et al. Angioplasty and stent for renal artery lesions (ASTRAL trial): Rationale, methods, and results so far. J Hum Hypertens 21 (2007) 511-515
99. Rocha-Singh K., Jaff M.R., Kelley E.L., et al. Renal artery stenting with noninvasive duplex ultrasound follow-up: 3-year results from the RENAISSANCE renal stent trial. Catheter Cardiovasc Interv 72 (2008) 853-862
100. Cooper C.J., Murphy T.P., Matsumoto A., et al. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: Rationale and design of the CORAL trial. Am Heart J 152 (2006) 59-66
101. Dubel G.J., and Murphy T.P. Distal embolic protection for renal arterial interventions. Cardiovasc Interv Radiol 31 (2008) 14-22
102. Cooper C.J., Haller S.T., Coyler W., et al. Embolic protection and platelet inhibition during renal artery stenting. Circulation 117 (2008) 2752-2760
103. Holden A., Hill A., Jaff M.R., et al. renal artery stent revascularization with embolic protection in patients with ischemic nephropathy. Kidney Int 70 (2006) 948-955
104. Edwards M.S., Craven B.L., Stafford J., et al. Distal embolic protection during renal artery angioplasty and stenting. J Vasc Surg 44 (2006) 128-135
105. Kougias P., El Sayed H.F., Zhow W., et al. Management of chronic mesenteric ischemia. The role of endovascular therapy. J Endovasc Ther 14 (2007) 395-405
106. Herbert G.S., and Steele S.R. Acute and chronic mesenteric ischemia. Surg Clin North Am 87 (2007) 1115-1134
107. Acosta S., Ogren M., Sternby N.H., et al. Fatal nonocclusive mesenteric ischaemia: Population-based incidence and risk factors. J Intern Med 259 3 (2006) 305-313
108. Park W.M., Cherry K.J., Chua H.K., et al. Current results of open revascularization for chronic mesenteric ischemia: A standard for comparison. J Vasc Surg 35 (2002) 853-859
109. Sarac T.P., Altinel O., Kashyap V., et al. Endovascular treatment of stenotic and occluded visceral arteries for chronic mesenteric ischemia. J Vasc Surg 47 (2008) 485-491
110. Silva J.A., White C.J., Collins T.J., et al. Endovascular therapy for chronic mesenteric ischemia. J Am Coll Cardiol 47 (2006) 944-950
111. Brown D.J., Schermerhorn M.L., Powell R.J., et al. Mesenteric stenting for chronic mesenteric ischemia. J Vasc Surg 42 (2005) 268-274
112. Landis M.S., Rajan D.K., Simons M.E., et al. Percutaneous management of chronic mesenteric ischemia: Outcomes after intervention. J Vasc Interv Radiol 16 (2005) 1319-1325
113. Saeed A., Saeed A., Solis J., et al. Longevity of superior mesenteric artery stents. [abstract]. JACC Cardiovascular Interventions (2009) (in press)
114. Sivamurthy N., Rhodes J.M., Lee D., et al. Endovascular versus open mesenteric revascularization: Immediate benefits do not equate with short-term functional outcomes. J Am Coll Surg 202 (2006) 859-867
115. Lim R.P., Dowling R.J., and Thomson K.R. Angioplasty and stenting of the superior mesenteric in acute mesenteric ischemia. Australas Radiol 48 (2004) 426-429
116. de Vries S.O., and Hunink M.G. Results of aortic bifurcation grafts for aortoiliac occlusive disease: A meta-analysis. J Vasc Surg 26 (1997) 558-569
117. Bosch J.L., and Hunink M.G. Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 204 (1997) 87-96
118. d'Othee B.J., Haulon S., Mounier-Vehier C., et al. Percutaneous endovascular treatment for stenoses and occlusions of infrarenal aorta and aortoiliac bifurcation: Midterm results. Eur J Vasc Endovasc Surg 24 (2002) 516-523
119. Greiner A., Dessl A., Klein-Weigel P., et al. Kissing stents for treatment of complex aortoiliac disease. Eur J Vasc Endovasc Surg 26 (2003) 161-165
120. Greiner A., Muhlthaler H., Neuhauser B., et al. Does stent overlap influence the patency rate of aortoiliac kissing stents?. J Endovasc Ther 12 (2005) 696-703
121. Houston J.G., Bhat R., Ross R., et al. Long-term results after placement of aortic bifurcation self-expanding stents: 10 year mortality, stent restenosis, and distal disease progression. Cardiovasc Interv Radiol 30 (2007) 42-47
122. Maynar M., Zander T., Qian Z., et al. Bifurcated endoprosthesis for treatment of aortoiliac occlusive lesions. J Endovasc Ther 12 (2005) 22-27
123. Mendelsohn F.O., Santos R.M., Crowley J.J., et al. Kissing stents in the aortic bifurcation. Am Heart J 136 (1998) 600-605
124. Mohamed F., Sarkar B., Timmons G., et al. Outcome of "Kissing stents" for aortoiliac atherosclerotic disease, including the effect on the non-diseased contralateral iliac limb. Cardiovasc Interv Radiol 25 (2002) 472-475
125. Piffaretti G., Tozzi M., Lomazzi C., et al. Mid-term results of endovascular reconstruction for aorto-iliac obstructive disease. Int Angiol 26 1 (2007) 18-25
126. Scheinert D., Schroder M., Balzer J.O., et al. Stent-supported reconstruction of the aortoiliac bifurcation with the kissing balloon technique. Circulation 100 (1999) II295-II300 (19)(suppl)
127. Yilmaz S., Sindel T., Golbasi I., et al. Aortoiliac kissing stents: Long-term results and analysis of risk factors affecting patency. J Endovasc Ther 13 (2006) 291-301
128. Mouanoutoua M., Maddikunta R., Allaqaband S., et al. Endovascular intervention of aortoiliac occlusive disease in high-risk patients using the kissing stents technique: Long-term results. Catheter Cardiovasc Interv 60 (2003) 320-326
129. Ameli F.M., Stein M., Provan J.L., et al. Predictors of surgical outcome in patients undergoing aortobifemoral bypass reconstruction. J Cardiovasc Surg 30 (1990) 333-339
130. Johnston K.W., Rae M., Hogg-Johnston S.A., et al. 5-Year results of a prospective study of percutaneous transluminal angioplasty. Ann Surg 206 (1987) 403-413
131. Vorwerk D., Günther R.W., Schürmann K., et al. Primary stent placement for chronic iliac artery occlusions: Follow-up results in 103 patients. Radiology 194 (1995) 745-749
132. Vorwerk D., Günther R.W., Schürmann K., et al. Aortic and iliac stenoses: Follow-up results of stent placement after insufficient balloon angioplasty in 118 cases. Radiology 198 (1996) 45-48
133. Palmaz J.C., Laborde J.C., Rivera F.J., et al. Stenting of the iliac arteries with the Palmaz stent: Experience from a multicenter trial. Cardiovasc Interv Radiol 15 (1992) 291-297
134. Scheinert D., Schröder M., Ludwig J., et al. Stent-supported recanalization of chronic iliac artery occlusions. Am J Med 110 (2001) 708-715
135. Timaran C.H., Ohki T., Gargiulo N.J., et al. Iliac artery stenting in patients with poor distal runoff: Influences of concomitant infrainguinal arterial reconstruction. J Vasc Surg 38 (2003) 479-484
136. Wilson S.E., Wolf G.L., and Cross A.P. Percutaneous transluminal angioplasty versus operation for peripheral arteriosclerosis: Report of a prospective randomized trial in a selected group of patients. J Vasc Surg 9 (1989) 1-9
137. Holm J., Arfvidsson B., Jivegard L., et al. Chronic lower limb ischaemia: A prospective randomised controlled study comparing the 1-year results of vascular surgery and percutaneous transluminal angioplasty (PTA). Eur J Vasc Surg 5 (1991) 517-522
138. Murphy T.P., Ariaratnam N.S., Carney Jr. W.I., et al. Aortoiliac insufficiency: Long-term experience with stent placement for treatment. Radiology 231 (2004) 243-249
139. Park K.B., Do Y.S., Kim J.H., et al. Stent placement for chronic iliac arterial occlusive disease: The results of 10 years experience in a single institution. Korean J Radiol 6 (2005) 256-266
140. Henry M., Amor M., Ethevenot G., et al. Palmaz stent placement in iliac and femoropopliteal arteries: Primary and secondary patency in 310 patients with 2-4-year follow-up. Radiology 197 (1995) 167-174
141. Ponec D., Jaff M.R., Swischuk J., et al., CRISP Study Investigators. The nitinol SMART stent vs Wallstent for suboptimal iliac artery angioplasty: CRISP-US trial results. J Vasc Interv Radiol 15 (2004) 911-918
142. Wolf G.L., Wilson S.E., Cross A.P., et al. Surgery or balloon angioplasty for peripheral vascular disease. A randomized clinical trial. Principal investigators and their Associates of Veterans Administration cooperative Study Number 199. J Vasc Interv Radiol 4 (1993) 639-648
143. Adam D.J., Beard J.D., Cleveland T., et al. BASIL trial participants. bypass versus angioplasty in severe ischaemia of the leg (BASIL): Multicenter, randomszed controlled trial. Lancet 366 (2005) 1925-1934
144. Springhorn M.E., Kinney M., Littooy F.N., et al. Inflow atherosclerotic disease localized to the common femoral artery: Treatment and outcome. Ann Vasc Surg 5 (1991) 234-240
145. Mukherjee D., and Inahara T. Endarterectomy as the procedure of choice for atherosclerotic occlusive lesions of the common femoral artery. Am J Surg 157 (1989) 498-500
146. Silva J.A., White C.J., Quintana H., et al. Percutaneous revascularization of the common femoral artery for limb ischemia. Catheter Cardiovasc Interv 62 (2004) 230-233
147. Mahmud E., Keramati S., Salami A., et al. Expanded applications of rotational atherectomy in contemporary coronary and peripheral interventional practice. J Invasive Cardiol 17 (2005) 207-210
148. Silva J.A., White C.J., Ranee S.R., et al. Percutaneous profundoplasty in the treatment of lower extremity ischemia: Results of long-term surveillance. J Endovasc Ther 8 (2001) 75-82
149. Jacobs D.L., Montaganahalli R.L., Cox D.E., et al. True lumen re-entry to facilitate subintimal angioplasty and stenting of total chronic occlusion. J Vasc Surg 43 (2006) 1291-1296
150. Lin S., and Mckinsey J.F. Plaque excision for the treatment of infrainguinal arterial occlusive disease. Tech Vasc Interv Radiol 8 (2005) 165-168
151. Scheinert D., Scheinert S., Sax J., et al. Prevalence of clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 45 (2005) 312-315
152. Cejna M., Thurnher S., Illiasch H., et al. PTA v Palmaz Stent placement in femoropopliteal artery obstructions: A multicenter prospective randomized study. J Vasc Interv Radiol 12 (2001) 23-31
153. Zdanowski Z., Albrechtsson U., Lundin A., et al. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions?. A randomized controlled study. Int Angiol 18 (1999) 251-255
154. Vroegindeweij D., Vos L.D., Tielbeek A.V., et al. Balloon angioplasty combined with primary stenting versus balloon angioplasty alone in femoropopliteal obstructions: A comparative randomized study. Cardiovasc Interv Radiol 20 (1997) 420-425
155. Zeller T., Tiefenbacher C., Steinkamp H.J., et al. Nitinol stent implantation in TASC A and B superficial femoral artery lesions: The femoral artery Conformexx trial (FACT). J Endovasc Ther 15 (2008) 390-398
156. Grimm J., Müller-Hulsbeck S., Jahnke T., et al. Randomized study to compare PTA alone versus PTA with Palmaz stent placement for femoropopliteal lesions. J Vasc Interv Radiol 12 (2001) 935-941
157. Becquemin J.-P., Favre J.-P., and Marzelle J. Systematic versus selective stent placement after superficial femoral artery balloon angioplasty: A multicenter prospective randomized study. J Vasc Surg 37 (2003) 487-494
158. Henriksen L.O., Jorgensen B., Holstein P.E., et al. Percutaneous transluminal angioplasty of infrarenal arteries in intermittent claudication. Acta Chir Scand 154 (1988) 573-576
159. Krepel V.M., van Andel G.J., van Erp W.F., et al. Percutaneous transluminal angioplasty of the femoropopliteal artery: Initial and long-term results. Radiology 156 (1985) 325-328
160. Kandarpa K., Becker G.J., Hunink M.G., et al. Transcatheter interventions for the treatment of peripheral atherosclerotic lesions. Part 1. J Vasc Interv Radiol 12 (2001) 683-695
161. Muradin G.S., Bosch J.L., Stijnen T., et al. Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: Meta-analysis. Radiology 221 (2001) 137-145
162. Duda S.H., Pusich B., Richter G., et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: Six-month results. Circulation 106 (2002) 1505-1509
163. Sabeti S., Mlekusch W., Amighi J., et al. Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries. J Endovasc Ther 12 (2005) 6-12
164. Duda S.H., Bosiers M., Lammer J., et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: The sirocco II trial. J Vasc Interv Radiol 16 (2005) 331-338
165. Sabeti S., Schillinger M., Amighi J., et al. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: Propensity score-adjusted analysis. Radiology 232 (2004) 516-521
166. Lugmayr H.F., Holzer H., Kastner M., et al. Treatment of complex arteriosclerotic lesions with nitinol stents in the superficial femoral and popliteal arteries: A midterm follow-up. Radiology 222 (2002) 37-43
167. Schillinger M., Sabeti S., Loewe C., et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354 (2006) 1879-1888
168. Schillinger M., Sabeti S., Dick P., et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 115 (2007) 2745-2749
169. Krankenberg H., Schlüter M., Steinkamp H.J., et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: The femoral artery stenting trial (FAST). Circulation 116 (2007) 285-292
170. Ferreira M., Lanziotti L., Monteiro M., et al. superficial femoral artery recanalization with self-expanding nitinol stents: Long-term follow up results. Eur J Vasc Endovasc Surg 34 (2007) 702-708
171. Dorrucci V. Treatment of superficial femoral artery occlusive disease. J Cardiovasc Surg 45 (2004) 193-201
172. Kedora J., Hohmann S., Garrett W., et al. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J Vasc Surg 45 (2007) 10-16
173. Kazemi S., Tumuluri R., Allaqaband S., et al. Percutaneous revascularization of femoropopliteal arteries with self-expanding nitinol stents-Immediate success and one-year results. J Am Coll Cardiol 3 suppl 1 (2005) 68A
174. Alimi Y., Hakam Z., Hartung O., et al. Efficacy of Viabahn in the treatment of severe superficial femoral artery lesions: Which factors influence long term patency?. Eur J Vasc Endovasc Surg 35 (2008) 346-352
175. McQuade K., Gable D., Hohman S., et al. Randomized comparison of ePTFE/nitinol self-expanding stent-graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vasc Surg 49 (2009) 109-116
176. Djelmani-Hani M., Nazir A., Taha M., et al. VIABAHN stent-graft for symptomatic recurrent in-stent restenosis of superficial femoral artery: Immediate success and long term patency. [Abstracts]. MJ Cardiol 100 8 (2007) 199L
177. Ramaiah V., Gammon R., Kiesz S., et al. Midterm outcomes from the TALON Registry: Treating peripherals with SilverHawk: Outcomes collection. J Endovasc Ther 13 (2006) 592-602
178. Zeller T., Rastan A., Schwärzwalder U., et al. Percutaneous peripheral atherectomy of femoropopliteal stenoses using a new-generation device: Six-month results from a single-center experience. J Endovasc Ther 11 (2004) 676-685
179. Suri R., Wholey M.H., Postoak D., et al. Distal embolic protection during femoropopliteal atherectomy. Catheter Cardiovasc Interv 67 (2006) 417-422
180. Zeller T., Rastan A., Sixt S., et al. Long-term results after directional atherectomy of femoropopliteal lesions. J Am Coll Cardiol 48 (2006) 1573-1578
181. Steinkamp H.J., Rademaker J., Wissgott C., et al. Percutaneous transluminal laser angioplasty versus balloon dilation for treatment of popliteal artery occlusions. J Endovasc Ther 9 (2002) 882-888
182. Scheinert D., Laird Jr. J.R., Schöroder M., et al. Excimer laser-assisted recanalization of long, chronic superficial femoral artery occlusions. J Endovasc Ther 8 (2001) 156-166
183. Bosiers M., Peeters P., Elist F.V., et al. excimer laser assisted angioplasty for critical limb ischemia. results of the LACI Belgium study. Eur J Vasc Endovasc Surg 29 (2005) 613-619
184. Laird J., Jaff M.R., Biamino G., et al. Cryoplasty for the treatment of femoropopliteal arterial disease: Results of a prospective, multicenter registry. J Vasc Interv Radiol 16 (2005) 1067-1073
185. United States Food and Drug Administration. Center for Devices and Radiological Health. Class 1 Recall: Boston Scientific Flextome Cutting Balloon Systems. http://www.fda.gov/cdrh/recalls/recall-120705.html Accessed January 29, 2009
186. Diehm N., Silvestro A., Do D.D., et al. Endovascular brachytherapy after femoropopliteal balloon angioplasty fails to show robust clinical benefit over time. J Endovasc Ther 12 (2005) 723-730
187. Wolfram R.M., Budinsky A.C., Pokrajac B., et al. Endovascular brachytherapy for prophylaxis of restenosis after femoropopliteal angioplasty: Five-year follow-up: Prospective randomized study. Radiology 240 (2006) 878-884
188. Wolfram R.M., Budinsky A.C., Pokrajac B., et al. Endovascular brachytherapy: Restenosis in de novo versus recurrent lesions of femoropopliteal artery: The Vienna experience. Radiology 236 (2005) 338-342
189. Therasse E., Donath D., Lesperance J., et al. External beam radiation to prevent restenosis after superficial femoral artery balloon angioplasty. Circulation 111 (2005) 3310-3315
190. Tepe G., Zeller T., Albretch T., et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 358 (2008) 689-699
191. Rosenfield K., Schainfield R., Pieczek A., et al. Restenosis of endovascular stents from stent compression. J Am Coll Cardiol 29 (1997) 328-338
192. Schlager O., Dick P., Sabeti S., et al. Long-segment-SFA stenting-the dark sides: In-stent restenosis, clinical deterioration and stent fractures. J Endovasc Ther 12 (2005) 676-684
193. Veith F.J., Gupta S.K., Ascer E., et al. Improved strategies for secondary operations on infrainguinal arteries. Ann Vasc Surg 4 (1990) 85-93
194. Ascer E., Collier P., Gupta S.K., et al. Reoperation for polytetrafluoroethylene bypass failure: The importance of distal outflow site and operative technique in determining outcome. J Vasc Surg 5 (1987) 298-310
195. Veith F.J., Gupta S.K., Wengerter K.R., et al. Changing arteriosclerotic disease patterns and management strategies in lower-limb threatening ischemia. Ann Surg 212 (1990) 412-414
196. Bakal C.W., Cynamon J., and Sprayregan S. Infrapopliteal percutaneous transluminal angioplasty: What we know. Radiology 200 (1996) 33-43
197. Schwarten D.E., and Cutcliff W.B. Arterial occlusive disease below the knee: Treatment with percutaneous transluminal angioplasty with low profile catheters and steerable guide wires. Radiology 169 (1988) 71-74
198. Hayes P.D., Chokkalingam A., Jones R., et al. Arterial perforation during infrainguinal lower limb angioplasty does not worsen outcome: Results from 1409 patients. J Endovasc Ther 9 (2002) 422-427
199. Siablis D., Kraniotis P., Karnabatidis D., et al. Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study. J Endovasc Ther 12 (2005) 685-695
200. Söder H.K., Manninen H.I., Jaakkola P., et al. Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: Angiographic and clinical results. J Vasc Interv Radiol 11 (2000) 1021-1031
201. Tsetis D., and Belli A.M. The role of infrapopliteal angioplasty. Br J Radiol 77 (2004) 1007-1015
202. Scheinert D., Ulrich M., Scheinert S., et al. Comparison of sirolimus-eluting vs baremetal stents for the treatment of infrapopliteal obstructions. Eurointervention 2 (2006) 169-174
203. Bakal C.W., Sprayregen S., Scheinbaum K., et al. Percutaneous transluminal angioplasty of the infrapopliteal arteries: Results in 53 patients. AJR Am J Roentgenol 154 (1990) 171-174
204. Sivananthan U.M., Browne T.F., Thorley P.J., et al. Percutaneous transluminal angioplasty of the tibial arteries. Br J Surg 81 (1994) 1282-1285
205. Varty K., Bolia A., Naylor A.R., et al. Infrapopliteal percutaneous transluminal angioplasty: A safe and successful procedure. Eur J Vasc Endovasc Surg 9 (1995) 341-345
206. Dorros G., Jaff M.R., Murphy K.J., et al. The acute outcome of tibioperoneal vessel angioplasty in 417 cases with claudication and critical limb ischemia. Catheter Cardiovasc Diagn 45 (1998) 251-256
207. Desgranges P., Kobeiter K., d'Audiffret A., et al. Acute occlusion of popliteal and/or tibial arteries: The value of percutaneous treatment. Eur J Vasc Endovasc Surg 20 (2000) 138-145
208. Hagino R.T., Fujitani R.M., Dawson D.L., et al. Does infrapopliteal arterial runoff predict success for popliteal artery aneurysmorrhaphy?. Am J Surg 168 6 (1994) 652-656
209. Dorros G., Jaff M.R., Dorros A.M., et al. Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: Five-year follow-up. Circulation 104 (2001) 2057-2062
210. Tsetis D.K., Michalis L.K., Rees M.R., et al. Vibrational angioplasty in the treatment of chronic infrapopliteal arterial occlusions: Preliminary experience. J Endovasc Ther 9 (2002) 889-895
211. Rastogi S., and Stavropoulos S.W. Infrapopliteal angioplasty. Tech Vasc Interv Radiol 7 (2004) 33-39
212. Spinosa D.J., Leung D.A., Matsumoto A.H., et al. Percutaneous intentional extraluminal recanalization in patients with chronic critical limb ischemia. Radiology 232 (2004) 499-507
213. Nasr M.K., McCarthy J., Hardman J., et al. The increasing role of percutaneous transluminal angioplasty in the primary management of critical limb ischaemia. Eur J Vasc Endovasc Surg 23 (2002) 398-403
214. Rand T., Basile A., Cejna M., et al. PTA versus carbofilm-coated stents in infrapopliteal arteries: Pilot study. Cardiovasc Interv Radiol 29 (2006) 29-38
215. Faglia E., Mantero M., Caminiti M., et al. Extensive use of peripheral angioplasty, particularly infrapopliteal, in the treatment of ischaemic diabetic foot ulcers: Clinical results of a multicentric study of 221 consecutive diabetic subjects. J Intern Med 252 (2002) 225-232
216. Faglia E., Dalla P.L., Clerici G., et al. Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: Prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg 29 (2005) 620-627
217. Bull P.G., Mendel H., Hold M., et al. Distal popliteal and tibioperoneal transluminal angioplasty: Long-term follow up. J Vasc Interv Radiol 3 (1992) 45-53
218. Brown K.T., Moore E., Getrajdman G.I., et al. Infrapopliteal angioplasty; long-term follow up. J Vasc Interv Radiol 4 (1993) 139-144
219. Tamura S., Sniderman K.W., Beinart C., et al. Percutaneous transluminal angioplasty of the popliteal artery and its branches. Radiology 143 (1982) 645-648
220. Abdul Raouf A., Rouleau Y., Clement A., et al. Endoluminal angioplasty of the popliteal artery. review of 54 consecutive patients. Eur J Vasc Endovasc Surg 30 (2005) 610-613
221. Shalev Y., Fortsas M.J., Schmidt D.H., et al. A modification of the peripheral angioplasty procedure to treat below-the-knee vascular disease: Initial success and late outcome in 97 patients. J Am Coll Cardiol 27 (1996) 191A
222. Grant A.G., White C.J., Collins T.J., et al. Infrapopliteal drug-eluting stents for chronic limb ischemia. Circulation 114 Suppl II (2006) II-820
223. Feiring A.J., Wesolowski A.A., and Lade S. Primary stent supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: Early and one year outcomes. J Am Coll Cardiol 44 (2004) 2307-2314
224. Commeau P., Barragan P., and Roguebert P.O. Sirolimus for below the knee lesions: mid-term results of SiroBTK study. Catheter Cardiovasc Interv 68 (2006) 793-798
225. Bosiers M., Deloose K., Verbist J., et al. Percutaneous transluminal angioplasty for treatment of '"below-the-knee"' critical limb ischemia: Early outcomes following the use of sirolimus-eluting stents. J Cardiovasc Surg 47 (2006) 171-176
226. Siablis D., Karnabatidis D., Katsanos K., et al. Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: Enduring 1 year angiographic and clinical benefit. J Endovasc Ther 14 2 (2007) 241-250
227. Tepe G. Drug-eluting stents for infrainguinal occlusive disease: Progress and challenges. Semin Vasc Surg 19 (2006) 102-108
228. Bosiers M., Hart J.P., Deloose K., et al. Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: Experience with 443 infrapopliteal procedures. Vascular 14 (2006) 63-69
229. Braithwaite B.D., Davies B., Birch P.A., et al. Management of acute leg ischemia in the elderly. Br J Surg 85 (1998) 217e 220
230. Blaisdell F.W., Steele M., and Allen R.E. Management of acute lower extremity arterial ischemia due to embolism and thrombosis. Surgery 84 (1978) 822-834
231. Clason A.E., Stonebridge P.A., Duncan A.J., et al. Morbidity and mortality in acute lower limb ischaemia: A 5-year review. Eur J Vasc Surg 3 (1989) 339-343
232. Ouriel K. Endovascular techniques in the treatment of acute limb ischemia: Thrombolytic agents, trials, and percutaneous mechanical thrombectomy techniques. Semin Vasc Surg 16 (2003) 270-279
233. STILE Investigators. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg 220 (1994) 251-266
234. Ouriel K., Shortell C., Deweese J., et al. A comparison of thrombolytic therapy with operative revascularization in the initial treatment of acute peripheral arterial ischemia. J Vasc Surg 19 (1994) 1021-1030
235. Ouriel K., Veith F.J., and Sasahara A.A. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N Engl J Med 338 (1998) 1105-1111
236. Palfreyman S.J., Booth A., and Michaels J.A. A systematic review of intra-arterial thrombolytic therapy for lower-limb ischaemia. Eur J Vasc Endovasc Surg 19 2 (2000) 143-157
237. Berridge D.C., Kessel D., and Robertson I. Surgery versus thrombolysis for acute limb ischaemia: Initial management. Cochrane Database Syst Rev 3 (2002) CD002784
238. Swischuk J.L., Fox P.F., Young K., et al. Transcatheter intraarterial infusion of rt-PA for acute lower limb ischemia: Results and complications. J Vasc Interv Radiol 12 (2001) 423-430
239. Nehler M.R., Mueller R.J., McLafferty R.B., et al. Outcome of catheter-directed thrombolysis for lower extremity arterial bypass occlusion. J Vasc Surg 37 (2003) 72-78
240. McNamara T.O., and Fischer J.R. Thrombolysis of peripheral arterial and graft occlusions: Improved results using high-dose urokinase. AJR Am J Roentgenol 144 (1985) 769-775
241. Sullivan K.L., Gardiner Jr. G.A., Shapiro M.J., et al. Acceleration of thrombolysis with a high-dose transthrombus bolus technique. Radiology 173 (1989) 805-808
242. Valji K., Bookstein J.J., Roberts A.C., et al. Pulse-spray pharmacomechanical thrombolysis of thrombosed hemodialysis access grafts: Long-term experience and comparison of original and current techniques. AJR Am J Roentgenol 164 (1995) 1495-1500
243. Armon M.P., Yusuf S.W., Whitaker S.C., et al. Results of 100 cases of Puls-espray thrombolysis for acute and subacute leg ischaemia. Br J Surg 84 (1997) 47-50
244. Kandarpa K., Chopra P.S., Aruny J.E., et al. Intraarterial thrombolysis of lower extremity occlusions: Prospective, randomized comparison of forced periodic infusion and conventional slow continuous infusion. Radiology 188 (1993) 861-867
245. Braithwaite B.D., Buckenham T.M., Galland R.B., et al. Prospective randomized trial of high-dose bolus versus low-dose tissue plasminogen activator infusion in the management of acute limb ischaemia. Thrombolysis Study Group. Br J Surg 84 (1997) 646-650
246. Plate G., Jansson I., Forssell C., et al. Thrombolysis for acute lower limb ischaemia-A prospective, randomised, multicenter study comparing two strategies. Eur J Vasc Endovasc Surg 31 (2006) 651-660
247. Silva J.A., Ramee S.R., Collins T.J., et al. Rheolytic thrombectomy in the treatment of acute limb-threatening ischemia: Immediate results and six-month follow-up of the multicenter AngioJet registry. Possis Peripheral AngioJet Study AngioJet Investigators. Catheter Cardiovasc Diagn 45 (1998) 386-393
248. Wagner H.J., Müller-Hülsbeck S., Pitton M.B., et al. Rapid thrombectomy with a hydrodynamic catheter: Results from a prospective, multicenter trial. Radiology 205 (1997) 675-681
249. Ansel G.M., Botti C.F., and Silver M.J. Treatment of acute limb ischemia with a percutaneous mechanical thrombectomy-based endovascular approach: 5-year limb salvage and survival results from a single center series. Catheter Cardiovasc Interv 72 (2008) 325-330
250. Ansel G.M., George B.S., Botti C.F., et al. Rheolytic thrombectomy in the management of limb ischemia: 30-Day results from a multicenter registry. J Endovasc Ther 9 (2002) 395-402
251. Allie D.E., Hebert C.J., Lirtzman M.D., et al. Novel simultaneous combination chemical thrombolysis/rheolytic thrombectomy therapy for acute critical limb ischemia: The power-pulse spray technique. Catheter Cardiovasc Interv 63 (2004) 512-522
252. Shammas N.W., Dippel E.J., Shammas G., et al. Dethrombosis of the lower extremity arteries using the power-pulse spray technique in patients with recent onset thrombotic occlusions: Results of the DETHROMBOSIS Registry. J Endovasc Ther 15 (2008) 570-579
253. Grossman P.M., Mendelsohn F., Henry T.D., et al. Results from a Phase II multicenter, double-blind placebo-controlled study of del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease. Am Heart J 153 (2007) 874-880
254. Mann M.J., Whittemore A.D., Donaldson M.C., et al. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: The PREVENT single-centre, randomised, controlled trial. Lancet 354 (1999) 1493-1498
255. Comerota A.J., Throm R.C., Miller K.A., et al. Naked plasmid DNA encoding fibroblast growth factor Type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: Preliminary results of a Phase I trial. J Vasc Surg 35 (2002) 930-936
256. Henry T.D., Mendelsohn F., Comerota A., et al. Dose and regimen effects of intramuscular NV1FGF in patients with critical limb ischemia: A randomized, double-blind, placebo-controlled study. Eur Heart J 27 suppl 1 (2006) 235
257. Nikol S., Baumgartner I., Van Belle E., et al., TALISMAN 201 Investigators. Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia. Mol Ther 16 (2008) 972-978
258. Cooper Jr. L.T., Hiatt W.R., Creager M.A., et al. Proteinuria in a placebo-controlled study of basic fibroblast growth factor for intermittent claudication. Vasc Med 6 (2001) 235-239
259. Lazarous D.F., Unger E.F., Epstein S.E., et al. Basic fibroblast growth factor in patients with intermittent claudication: Results of a Phase I trial. J Am Coll Cardiol 36 (2000) 1239-1244
260. Lederman R.J., Mendelsohn F.O., Anderson R.D., et al., TRAFFIC Investigators. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): A randomised trial. Lancet 359 (2002) 2053-2058
261. Marui A., Tabata Y., Kojima S., et al. A novel approach to therapeutic angiogenesis for patients with critical limb ischemia by sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogel: An initial report of the Phase I-IIa study. Circul J 71 (2007) 1181-1186
262. Matyas L., Schulte K.L., Dormandy J.A., et al. Arteriogenic gene therapy in patients with unreconstructable critical limb ischemia: A randomized, placebo-controlled clinical trial of adenovirus 5-delivered fibroblast growth factor-4. Hum Gene Ther 16 (2005) 1202-1211
263. Morishita R., Aoki M., Hashiya N., et al. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease erratum. Hypertension 48 (2006) e7 2004;44:203-9
264. Powell R.J., Simons M., Mendelsohn F.O., et al. Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia. Circulation 118 (2008) 58-65
265. Rajagopalan S., Olin J., Deitcher S., et al. Use of a constitutively active hypoxia-inducible factor-1alpha transgene as a therapeutic strategy in no-option critical limb ischemia patients: Phase I dose-escalation experience. Circulation 115 (2007) 1234-1243
266. Rajagopalan S., Mohler III E.R., Lederman R.J., et al. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: A Phase II randomized, double-blind, con-trolled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication. Circulation 108 (2003) 1933-1938
267. Isner J.M., Pieczek A., Schainfeld R., et al. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 348 (1996) 370-374
268. Isner J.M., Baumgartner I., Rauh G., et al. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: Preliminary clinical results. J Vasc Surg 28 (1998) 964-973
269. van Royen N., Schirmer S.H., Atasever B., et al. START Trial. A pilot study on stimulation of ARTteriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease. Circulation 112 (2005) 1040-1046
270. Clouse W.D., Hallett Jr. J.W., Schaff H.V., et al. Improved prognosis of thoracic aortic aneurysms: A population based study. J Am Med Assoc 280 (1998) 1926-1929
271. Katzen B.Y., Dake M.D., MacLean A.A., et al. Endovascular repair of abdominal and thoracic aortic aneurysms. Circulation 112 (2005) 1663-1675
272. Coady M.A., Rizzo J.A., Hammond G.L., et al. Surgical intervention criteria for thoracic aortic aneurysms: A study of growth rates and complications. Ann Thorac Surg 67 (1999) 1922-1926
273. Davies R.R., Goldstein L.J., Coady M.A., et al. Yearly rupture or dissection rates for thoracic aortic aneurysms: Simple prediction based on size. Ann Thorac Surg 73 (2002) 17-27
274. Bavaria J.E., Appoo J.J., Makaroun M.S., et al. Endovascular stent grafting versus open surgical repair of descending thoracic aortic aneurysms in low-risk patients: A multicenter comparative trial. J Thorac Cardiovasc Surg 133 (2007) 369-377
275. Hodges T.C., and Cronenwett J. Abdominal aortic and iliac artery aneurysms: Clinical presentation, natural history, and indications for intervention. In: Perler B.A., and Becker G.J. (Eds). Vascular Intervention: A Clinical Approach (1998), Thieme, New York, NY 339-350
276. Kaufman J.A., Geller S.C., Brewster D.C., et al. Endovascular repair of abdominal aortic aneurysms: Current status and future directions. AJR Am J Roentgenol 175 (2000) 289-302
277. Nevitt M.P., Ballard D.J., and Hallett J.W. Prognosis of abdominal aortic aneurysms. A population-based study. N Engl J Med 321 (1989) 1009-1014
278. Hallett Jr. J.W. Management of abdominal aortic aneurysms. Mayo Clin Proc 75 (2000) 395-399
279. Hollier L.H., Taylor Jr. L.M., and Ochsner J. Recommended indications for operative treatment of abdominal aortic aneurysms: Report of a subcommittee of the Joint Council of the Society for Vascular Surgery and the International Society for Cardiovascular Surgery. J Vasc Surg 15 (1992) 1046-1056
280. Hallett J.W., Marshall D.M., Petterson T.M., et al. Graft-related complications after abdominal aortic aneurysm repair: Reassurance from a 36-year population-based experience. J Vasc Surg 25 (1997) 277-286
281. Johnston K.W. Nonruptured abdominal aortic aneurysm: Six-year follow-up results from the multicenter prospective Canadian aneurysm study. Canadian Society for Vascular Surgery Aneurysm Study Group. J Vasc Surg 20 (1994) 163-170
282. Parodi J.C., Palmaz J.C., and Barone H.D. Transfemoral intraluminal graft implantation for abdominal aortic aneurysms. Ann Vasc Surg 5 (1991) 491-499
283. Longo G.M., and Eskandari M.K. Overview of success of EVAR: Progress to date. Semin Vasc Surg 17 (2004) 307-313
284. Zarins C.K., White R.A., Moll F.L., et al. The AneuRx stent-graft: Four-year results and worldwide experience 2000. J Vasc Surg 33 (2001) S135-S145
285. Buth J., van Marrewijk C.J., Harris P.L., et al. Outcome of endovascular abdominal aortic aneurysm repair in patients with conditions considered unfit for an open procedure: A report on the Eurostar experience. J Vasc Surg 35 (2002) 211-221
286. Leurs L.J., Bell R., Degrieck Y., et al. Endovascular treatment of thoracic aortic diseases: Combined experience from the Eurostar and UK thoracic endograft registries. J Vasc Surg 40 (2004) 670-680
287. Greenhalgh R.M., Allison D.J., Bell P.R., et al. Comparison of endovascular aneurysm repair with open repair in patients with abdominal aortic aneurysm (EVAR trial 1), 30-day operative mortality results: Randomized controlled trial. Lancet 364 (2004) 843-848
288. Greenhalgh R.M., Allison D.J., Bell P.R., et al. Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2): Randomized controlled trial. Lancet 365 (2005) 2187-2192
289. Prinssen M., Verhoeven E.L., Buth J., et al. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med 351 (2004) 1607-1618
290. Schermerhorn M.L., O'Malley A.J., Jhaveri R., et al. Endovascular vs. open repair of abdominal aortic aneurysms in the Medicare population. N Engl J Med 358 (2008) 464-474
291. Hallett Jr. J.W., Marshall D.M., Petterson T.M., et al. Graft-related complications after abdominal aortic aneurysm repair: Reassurance from a 36-year population-based experience. J Vasc Surg 25 (1997) 277-284
292. Biancari F., Ylonen K., Anttila V., et al. Durability of open repair of infrarenal abdominal aortic aneurysm: A 15-year follow-up study. J Vasc Surg 35 (2002) 87-93
293. Siami F.S., and Lifeline Registry of EVAR Publications Committee. Lifeline registry of endovascular aneurysm repair: Long-term primary outcome measures. J Vasc Surg 42 (2005) 1-10
294. May J., White G.H., Waugh R., et al. Improved survival after endoluminal repair with second-generation prostheses compared with open repair in the treatment of abdominal aortic aneurysms: A 5-year concurrent comparison using life table method. J Vasc Surg 33 2 (2001) S21-S26 (suppl)
295. Zarins C.K., and AneuRx Clinical Investigators. The US AneuRx Clinical Trial: 6-year clinical update 2002. J Vasc Surg 37 (2003) 904-908
296. Harris P.L., and Buth J. An update on the important findings from the Eurostar EVAR registry. Vascular 12 (2004) 33-38
297. Kibbe M.R., and Matsumura J.S. The Excluder Investigators: The Gore Excluder US Multi-Center Trial: Analysis of adverse events at 2 years. Semin Vasc Surg 16 (2003) 144-150
298. Matsumura J.S., Brewster D.C., Makaroun M.S., et al. A multicenter controlled clinical trial of open versus endovascular treatment of abdominal aortic aneurysm. J Vasc Surg 37 (2003) 262-271
299. Moore W.S. The Guidant Ancure bifurcation endograft: Five-year follow-up. Semin Vasc Surg 16 (2003) 139-143
300. Moore W.S., Matsumura J.S., Makaroun M.S., et al. Five-year interim comparison of the Guidant bifurcated endograft with open repair of abdominal aortic aneurysm. J Vasc Surg 38 (2003) 46-55
301. Greenberg R. The Zenith Investigators: The zenith AAA endovascular graft for abdominal aortic aneurysms: Clinical update. Semin Vasc Surg 16 (2003) 151-157
302. Sternbergh III W.C., Money S.R., Greenberg R.K., et al. Influence of endograft oversizing on device migration, endoleak, aneurysm shrinkage, and aortic neck dilation: Results from the Zenith Multicenter Trial. J Vasc Surg 39 (2004) 20-26
303. Bertges D.J., Chow K., Wyers M.C., et al. Abdominal aortic aneurysm size regression after endovascular repair is endograft dependent. J Vasc Surg 37 (2003) 716-723
304. Sachdev U., Baril D.T., Ellozy S.H., et al. Management of aneurysms involving branches of the celiac and superior mesenteric arteries: A comparison of surgical and endovascular therapy. J Vasc Surg 44 (2006) 718-724
305. Abbas M.A., Fowl R.J., Stone W.N., et al. Hepatic artery aneurysm: Factors that predict complications. J Vasc Surg 38 (2003) 41-45
306. Berceli S.A. Hepatic and splenic artery aneurysms. Semin Vasc Surg 18 (2005) 196-201
307. Nachbur B.H., Inderbitzi R.G., and Bar W. Isolated iliac aneurysms. Eur J Vasc Surg 5 (1991) 375-381 Richardson JW, Greenfield LJ
308. Richardson J.W., and Greenfield L.J. Natural history and management of iliac aneurysms. J Vasc Surg 8 (1988) 165-171
309. Scheinert D., Schroder M., Steinkamp H., et al. Treatment of iliac artery aneurysms by percutaneous implantation of stent grafts. Circulation 102 (2000) III-253-III-258
310. Sahgal A., Veith F., Lipsitz E., et al. Diameter changes in isolated iliac artery aneurysms 1 to 6 years after endovascular graft repair. J Vasc Surg 33 (2001) 289-295
311. Huand Y., Gloviczki P., Duncan A.A., et al. Common iliac artery aneurysm: Expansion rate and results of open surgical and endovascular repair. J Vasc Surg 47 (2008) 1203-1211
312. Pitoulias G.A., Donas K.P., Schulte S., et al. Isolated iliac artery aneurysms: Endovascular versus open elective repair. J Vasc Surg 46 (2007) 648-654
313. Trickett J.P., Scott R.A.P., and Tilney H.S. Screening and management of asymptomatic popliteal aneurysms. J Med Screen 9 (2002) 92-93
314. Curi M.A., Geraghty P.J., Merion O.A., et al. Mid-term outcomes of endovascular popliteal artery aneurysm repair. J Vasc Surg 45 (2007) 505-510
315. Thompson M.M., and Sayers R.D. Arterial aneurysms. Companion to Specialist Surgical Practice, Vol VII. Arterial Surgery (1998), WB Saunders, London
316. Dawson I., Sie R.B., and van Bockel J.H. Atherosclerotic popliteal aneurysm. Br J Surg 84 (1997) 293-299
317. Michaels J.A., and Galland R.B. Management of asymptomatic popliteal aneurysms: The use of a markov decision tree to determine the criteria for a conservative approach. Eur J Vasc Surg 7 (1993) 136-143
318. Tielliu I.F.J., Verhoeven E.L.G., Prins T.R., et al. Treatment of popliteal artery aneurysms with the Hemobahn stent-graft. J Endovasc Ther 10 (2003) 111-116
319. Antonello M., Frigatti P., Battocchio P., et al. Open repair versus endovascular treatment for asymptomatic popliteal artery aneurysm: Results of a prospective randomized study. J Vasc Surg 42 (2005) 185-193
320. Cina C.S., Moor R., Maggisano R., et al. Endovascular repair of popliteal artery aneurysms with anaconda limbs: Technique and early results. Catheter Cardiovasc Int 72 (2008) 716-724
321. Siauw R., Koh E.H., and Walker S.R. Endovascular repair of polyteal artery aneurysms: Techniques, current evidence and recent experience. Aust NZ J Surg 76 (2006) 505-511
322. Chang R., Horne M.K., Mayo D.J., et al. Pulse-spray treatment of subclavian and jugular venous thrombi with recombinant tissue plasminogen activator. J Vasc Interv Radiol 7 (1996) 845-851
323. Adelman M.A., Stone D.H., Riles T.S., et al. A multidisciplinary approach to the treatment of Paget-Schroetter syndrome. Ann Vasc Surg 11 (1997) 149-154
324. Kee S.T., Kinoshita L., Razavi M.K., et al. Superior vena cava syndrome: Treatment with catheter-directed thrombolysis and endovascular stent placement. Radiology 206 (1998) 187-193
325. Angle N., Gelabert H.A., Farooq M.M., et al. Safety and efficacy of early surgical decompression of the thoracic outlet outlet for Paget-Schroetter syndrome. Ann Vasc Surg 15 (2001) 37-42
326. Machleder H.I. Evaluation of a new treatment strategy for Paget-Schroetter syndrome: Spontaneous thrombosis of the axillary-subclavian vein. J Vasc Surg 17 (1993) 305-315
327. Molina J.E. Need for emergency treatment in subclavian vein effort thrombosis. J Am Coll Surg 181 (1995) 414-420
328. Urschel Jr. H.C., Razzuk M.A., and Paget-Schroetter. Syndrome: What is the best management?. Ann Thorac Surg 69 (2000) 1663-1668
329. Kreienberg P.B., Chang B.B., Darling III R.C., et al. Long-term results in patients treated with thrombolysis, thoracic inlet decompression, and subclavian vein stenting for Paget-Schroetter syndrome. J Vasc Surg 33 suppl (2001) S100-S105
330. Lokanathan R., Salvian A.J., Chen J.C., et al. Outcome after thrombolysis and selective thoracic outlet decompression for primary axillary vein thrombosis. J Vasc Surg 33 (2001) 783-788
331. Heit J.A., Melton III L.J., Lohse C.M., et al. Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clin Proc 76 (2001) 1102-1110
332. Fowkes F.J., Price J.F., and Fowkes F.G. Incidence of diagnosed deep vein thrombosis in the general population: Systematic review. Eur J Vasc Endovasc Surg 25 (2003) 1-5
333. Hansson P.O., Sörbo J., and Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis: Incidence and risk factors. Arch Intern Med 160 (2000) 769-774
334. Heit J.A., Mohr D.N., Silverstein M.D., et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: A population-based cohort study. Arch Intern Med 160 (2000) 761-768
335. Anderson Jr. F.A., Wheeler H.B., Goldberg R.J., et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism the Worcester DVT study. Arch Intern Med 151 (1991) 933-938
336. Gould M.K., Dembitzer A.D., Doyle R.L., et al. Low molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials. Ann Intern Med 130 (1999) 800-809
337. Hirsh J., Siragusa S., Cosmi B., et al. Low molecular weight heparins (LMWH) in the treatment of patients with acute venous thromboembolism. Thromb Haemost 74 (1995) 360-363
338. van Den Belt A.G., Prins M.H., Lensing A.W., et al. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev (2000) CD001100
339. Chong B.H., Brighton T.A., Baker R.I., et al., ASTH DVT Study Group. Once-daily enoxaparin in the outpatient setting versus unfractionated heparin in hospital for the treatment of symptomatic deep-vein thrombosis. J Thromb Thrombolysis 19 (2005) 173-181
340. Schulman S., Rhedin A.S., Lindmarker P., et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group. N Engl J Med 332 (1995) 1661-1665
341. Pinede L., Ninet J., Duhaut P., et al., Investigators of the Dure'e Optimale du Traitement AntiVitamines K" (DOTA VK) Study. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Circulation 103 (2001) 2453-2460
342. Ridker P.M., Goldhaber S.Z., Danielson E., et al., PREVENT Investigators. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 348 (2003) 1425-1434
343. Agnelli G., Prandoni P., Becattini C., et al., Warfarin Optimal Duration Italian Trial Investigators. Extended oral anticoagulant therapy after a first episode of pulmonary embolism. Ann Intern Med 139 (2003) 19-25
344. Prandoni P., Lensing A.W., Cogo A., et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 125 (1996) 1-7
345. Akesson H., Brudin L., Dahlström J.A., et al. Venous function assessed during a 5-year period after acute Ilio-femoral venous thrombosis treated with anticoagulation. Eur J Vasc Surg 4 (1990) 43-48
346. Saarinen J., Sisto T., Laurikka J., et al. Late sequelae of acute deep venous thrombosis: Evaluation five to ten years later. Phlebology 10 (1995) 106-109
347. Janssen M.C., Haenen J.H., van Asten W.M., et al. Clinical and hemodynamic sequelae of deep venous thrombosis: Retrospective evaluation after 7-13 years. Clin Sci 93 (1997) 7-12
348. Brandjes D.P.M., Büller H.R., Heijboer H., et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 349 (1997) 759-762
349. Elliot M.S., Immelman E.J., Jeffery P., et al. A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: An interim report of a prospective trial. Br J Surg 66 (1979) 838-843
350. Arnesen H., Høiseth A., and Ly B. Streptokinase or heparin in the treatment of deep vein thrombosis: Follow-up results of a prospective study. Acta Med Scand 211 (1982) 65-68
351. Meissner M.H., Manzo R.A., Bergelin R.O., et al. Deep venous insufficiency: The relationship between lysis and subsequent reflux. J Vasc Surg 18 (1993) 596-605 discussion, 606-8
352. Elsharawy M., and Elzayat E. Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. A randomised clinical trial. Eur J Vasc Endovasc Surg 24 (2002) 209-214
353. Mewissen M.W., Seabrook G.R., Meissner M.H., et al. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: Report of a national multicenter registry. Radiology 211 (1999) 39-49
354. Bjarnason H., Kruse J.R., Asinger D.A., et al. Iliofemoral deep venous thrombosis: Safety and efficacy outcome during 5 years of catheter-directed thrombolytic therapy. J Vasc Interv Radiol 8 (1997) 405-418
355. Semba C.P., and Dake M.D. Iliofemoral deep venous thrombosis: Aggressive therapy with catheter-directed thrombolysis. Radiology 191 (1994) 487-494
356. Razavi M.K., Wong H., Kee S.T., et al. Initial clinical results of tenecteplase (TNK) in catheter-directed thrombolytic therapy. J Endovasc Ther 9 (2002) 593-598
357. Raju S., Fountain T., and McPherson S.H. Catheter-directed thrombolysis for deep venous thrombosis. J Miss State Med Assoc 39 (1998) 81-84
358. Castaneda F., Li R., Young K., et al. Catheter directed thrombolysis in deep venous thrombosis with use of reteplase: Immediate results and complications from a pilot study. J Vasc Interv Radiol 13 (2002) 577-580
359. Horne III M.K., Mayo D.J., Cannon III R.O., et al. Intraclot recombinant tissue plasminogen activator in the treatment of deep venous thrombosis of the lower and upper extremities. Am J Med 108 (2000) 251-255
360. Ouriel K., Katzen B., Mewissen M., et al. Reteplase in the treatment of peripheral arterial and venous occlusions: A pilot study. J Vasc Interv Radiol 11 (2000) 849-854
361. Sugimoto K., Hofmann L.V., Razavi M.K., et al. The safety, efficacy, and pharmacoeconomics of low-dose alteplase compared with urokinase for catheter-directed thrombolysis of arterial and venous occlusions. J Vasc Surg 37 (2003) 512-517
362. Acharya G., Singh K., Hansen J.B., et al. Catheter-directed thrombolysis for the management of postpartum deep venous thrombosis. Acta Obstet Gynecol Scand 84 (2005) 155-158
363. Ogawa T., Hoshino S., Midorikawa H., et al. Intermittent pneumatic compression of the foot and calf improves the outcome of catheter-directed thrombolysis using low-dose urokinase in patients with acute proximal venous thrombosis of the leg. J Vasc Surg 42 (2005) 940-944
364. Laiho M.K., Oinonen A., Sugano N., et al. Preservation of venous valve function after catheter-directed and systemic thrombolysis for deep venous thrombosis. Eur J Vasc Endovasc Surg 28 (2004) 391-396
365. Sillesen H., Just S., Jørgensen M., et al. Catheter directed thrombolysis for treatment of Ilio-femoral deep venous thrombosis is durable, preserves venous valve function and may prevent chronic venous insufficiency. Eur J Vasc Endovasc Surg 30 (2005) 556-562
366. Grunwald M.R., and Hofmann L.V. Comparison of urokinase, alteplase, and reteplase for catheter-directed thrombolysis of deep venous thrombosis. J Vasc Interv Radiol 15 (2004) 347-352
367. Semba C.P., Razavi M.K., Kee S.T., et al. Thrombolysis for lower extremity deep venous thrombosis. Tech Vasc Interv Radiol 7 (2004) 68-78
368. May R., and Thurner J. A vascular spur in the vena iliaca communis sinistral as a cause of predominantly left-sided thrombosis of the pelvic veins. Z Kreislaufforsch 45 (1956) 912-922
369. May R., and Thurner J. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology 8 (1957) 419-427
370. Kim J.Y., Choi D., Guk Ko Y., et al. Percutaneous treatment of deep vein thrombosis in May-Thurner syndrome. Cardiovasc Interv Radiol 29 (2006) 571-575
371. Husmann M.J., Heller G., Kalka C., et al. Stenting of common iliac vein obstructions combined with regional thrombolysis and thrombectomy in acute deep vein thrombosis. Eur J Vasc Endovasc Surg 34 (2007) 87-91
372. Kearon C., Gent M., Hirsh J., et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 340 (1999) 901-907
373. Kearon C., Ginsberg J.S., Kovacs M.J., et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 349 (2003) 631-639
374. Schulman S., Granqvist S., Holmström M., et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. N Engl J Med 336 (1997) 393-398
375. Stein P.D., Kayali F., and Olson R.E. Twenty-one year trends in the use of inferior vena cava filters. Arch Intern Med 164 (2004) 1541-1545
376. Hann C.L., and Streiff M.B. The role of vena caval filters in the management of venous thromboembolism. Blood Rev 19 (2005) 179-202
377. Decousus H., Leizorovicz A., Parent F., et al., The PREPIC Study Group. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. the prévention du risque d'embolie pulmonaire par interruption randomized study. N Engl J Med 338 (1998) 409-415
378. PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: The PREPIC (prevention du risque d'embolie pulmonaire par interruption cave) randomized study. Circulation 112 (2005) 416-422
379. White R.H., Zhou H., Kim J., et al. A population-based study of the effectiveness of inferior vena cava filter use among patients with venous thromboembolism. Arch Intern Med 160 (2000) 2033-2041
380. Horattas M.C., Wright D.J., Fenton A.H., et al. Changing concepts of deep venous thrombosis of the upper extremity-Report of a series and review of the literature. Surgery 104 (1988) 561-567
381. Kammen B.F., and Soulen M.C. Phlegmasia cerulea dolens of the upper extremity. J Vasc Interv Radiol 6 (1995) 283-286
382. Bolitho D.G., Elwood E.T., and Roberts F. Phlegmasia cerulea dolens of the upper extremity. Ann Plast Surg 45 (2000) 644-646
383. Hingorani A., Ascher E., Lorenson E., et al. Upper extremity deep venous thrombosis and its impact on morbidity and mortality rates in a hospital-based population. J Vasc Surg 26 (1997) 853-860
384. Monreal M., Raventos A., Lerma R., et al. Pulmonary embolism in patients with upper extremity DVT associated to venous central lines-A prospective study. Thromb Haemost 72 (1994) 548-550
385. Roos D.B. Congenital anomalies associated with thoracic outlet syndrome: Anatomy, symptoms, diagnosis, and treatment. Am J Surg 132 (1976) 771-778
386. AbuRahma A.F., and Robinson P.A. Effort subclavian vein thrombosis: Evolution of management. J Endovasc Ther 7 (2000) 302-308
387. Rutherford R.B., and Hurlbert S.N. Primary subclavian-axillary vein thrombosis: Consensus and commentary. Cardiovasc Surg 4 (1996) 420-423
388. Yim C.D., Sane S.S., and Bjarnason H. Superior vena cava stenting. Radiol Clin North Am 38 (2000) 409-424
389. Schindler N., and Vogelzang R.L. Superior vena cava syndrome: Experience with endovascular stents and surgical therapy. Surg Clin North Am 79 (1999) 683-694
390. Stockx L., Raat H., Donck J., et al. Repositioning and leaving in situ the central venous catheter during percutaneous treatment of associated superior vena cava syndrome: A report of eight cases. Cardiovasc Interv Radiol 22 (1999) 224-226
391. Slonim S.M., Semba C.P., Sze D.Y., et al. Placement of SVC stents over pacemaker wires for the treatment of SVC syndrome. J Vasc Interv Radiol 11 (2000) 215-219
392. Bechtold R.E., Wolfman N.T., Karstaedt N., et al. Superior vena caval obstruction: Detection using CT. Radiology 157 (1985) 485-487
393. Kim H.J., Kim H.S., and Chung S.H. Diagnosis of superior vena cava syndrome: Importance of collateral vessels. AJR Am J Roentgenol 161 (1993) 539-542
394. Eren S., Karaman A., and Okur A. The superior vena cava syndrome caused by malignant disease. Imaging with multi-detector row CT. Eur J Radiol 59 (2006) 93-103
395. Lin J., Zhou K.R., Chen Z.W., et al. Vena cava 3D contrast-enhanced MR venography: A pictorial review. Cardiovasc Interv Radiol 28 (2005) 795-805
396. Thornton M.J., Ryan R., Varghese J.C., et al. A threedimensional gadolinium-enhanced MR venography technique for imaging central veins. AJR Am J Roentgenol 173 (1999) 999-1003
397. Rice T.W., Rodriguez R.M., and Light R.W. The superior vena cava syndrome: Clinical characteristics and evolving etiology. Medicine 85 (2006) 37-42
398. Markman M. Diagnosis and management of superior vena cava syndrome. Cleve Clin J Med 66 (1999) 59-61
399. Charnsangavej C., Carrasco C., Wallace S., et al. Stenosis of the vena cava: Preliminary assessment of treatment with expandable metallic stent. Radiology 161 (1986) 295-298
400. Mathias K., Jäger H., Willaschek J., et al. Interventional radiology in central venous obstructions. Dilatation-stent implantation-thrombolysis. Radiologe 38 (1998) 606-613
401. Sunder S.K., Ekong E.A., Sivalingam K., et al. Superior vena cava thrombosis due to pacing electrodes: Successful treatment with combined thrombolysis and angioplasty. Am Heart J 123 (1992) 790-792
402. Rowell N.P., and Gleeson F.V. Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus: A systematic review. Clin Oncol 14 (2002) 338-351
403. Ostler P.J., Clarke D.P., Watkinson A.F., et al. Superior vena cava obstruction: A modern management strategy. Clin Oncol 9 (1997) 83-89
404. Smayra T., Otal P., Chabbert V., et al. Long-term results of endovascular stent placement in the superior caval venous system. Cardiovasc Interv Radiol 24 (2001) 388-394
405. Nicholson A.A., Ettles D.F., Arnold A., et al. Treatment of malignant superior vena cava obstruction: Metal stents or radiation therapy. J Vasc Interv Radiol 8 (1997) 781-788
406. Crowe M.T., Davies C.H., and Gaines P.A. Percutaneous management of superior vena cava occlusions. Cardiovasc Interv Radiol 18 (1995) 367-372
407. Rizvi A.Z., Kalra M., Bjarnason H., et al. Benign superior vena cava syndrome: Stenting is now the first line of treatment. J Vasc Surg 47 (2008) 372-380
408. Lanciego C., Chacón J.L., Julián A., et al. Stenting as first option for endovascular treatment of malignant superior vena cava syndrome. AJR Am J Roentgenol 177 (2001) 585-593
409. Bissett D., Kaye S.B., Baxter G., et al. Successful thrombolysis of SVC thrombosis associated with Hickman lines and continuous infusion chemotherapy. Clin Oncol 8 (1996) 247-249
410. Barakat K., Robinson N.M., and Spurrell R.A. Transvenous pacing lead-induced thrombosis: A series of cases with a review of the literature. Cardiology 93 (2000) 142-148
411. Qanadli S.D., El Hajjam M., Mignon F., et al. Subacute and chronic benign superior vena cava obstructions: Endovascular treatment with self-expanding metallic stents. AJR Am J Roentgenol 173 (1999) 159-164
412. Edwards R.D., and Jackson J.E. Case report: Superior vena caval obstruction treated by thrombolysis, mechanical thrombectomy and metallic stents. Clin Radiol 48 (1993) 215-217